Comments
Loading...

Xilio Therapeutics (XLO) Stock Price, Quote, News & History

XLONASDAQ
Logo brought to you by Benzinga Data
$0.6288
0.01141.85%
At close: Jan 23, 4:00 PM EST
$0.6480
0.01923.05%
After Hours: Jan 23, 4:40 PM EST
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open
$0.64
Close
$0.63
Volume / Avg.
718.44K / 635.03K
Day Range
$0.62 - $0.65
52 Wk Range
0.57 - 1.70
Market Cap
$43.77M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
49
Short Interest
4.22%
Days to Cover
8.04

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-17.15M
Investing Cash Flow (TTM)
-429.00K
Financing Cash Flow (TTM)
60.11M
Free Cash Flow (TTM)
-17.58M
Capital Expenditure (TTM)
-429.00K
Net Change in Cash (TTM)
42.53M

Analyst Trends and Forecast

1
Aug 25
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$54.03M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
1.88
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-97.01%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.12

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
$0
Total Cash
$103.76M
Debt to Equity
-
Issuance of Debt (TTM)
$0
Repayment of Debt (TTM)
$0

Key Statistics

Open
$0.64
Close
$0.63
Volume / Avg.
718.44K / 635.03K
Day Range
$0.62 - $0.65
52 Wk Range
0.57 - 1.70
Market Cap
$43.77M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
49
Short Interest
4.22%
Days to Cover
8.04

About

Sector
Health Care
Industry
Biotechnology
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effe...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
XLO
GLTO

FAQ

Q

How do I buy Xilio Therapeutics (XLO) stock?

A

You can purchase shares of Xilio Therapeutics (NASDAQ:XLO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Xilio Therapeutics (XLO) competitors?

Q

What is the forecast, or price target, for Xilio Therapeutics (XLO) stock?

A

Xilio Therapeutics has a consensus price target of $5.75.

Q

What is the current price for Xilio Therapeutics (XLO)?

A

The stock price for Xilio Therapeutics (NASDAQ: XLO) is $0.648 last updated January 23, 2026 at 4:40 PM EST.

Q

Does Xilio Therapeutics (XLO) pay a dividend?

A

There are no upcoming dividends for Xilio Therapeutics.

Q

When is Xilio Therapeutics (NASDAQ:XLO) reporting earnings?

A

Xilio Therapeutics does not have any upcoming earnings scheduled.

Q

Is Xilio Therapeutics (XLO) going to split?

A

There is no upcoming split for Xilio Therapeutics.

Q

What sector and industry does Xilio Therapeutics (XLO) operate in?

A

Xilio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.